Article
Catestatin suppresses melanoma progression and drug resistance through multitargeted modulation of signaling pathways
2025-10-24
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Despite advances in targeted and immune-based therapies, melanoma remains one of the most aggressive and treatment-resistant cancers. Resistance to small-molecule inhibitors and immune checkpoint blockade highlights the need for new mechanistically distinct interventions. Catestatin (CST), a Chromogranin A (CgA)– derived peptide with immunomodulatory and reparative propertie...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dcb84358-a9c8-54fb-a85e-647d4cfacf1d
- DOI
- 10.1101/2025.10.22.684062
